Fibroblast Growth Factor Receptors as Therapeutic Targets in Human Melanoma: Synergism with BRAF Inhibition

Cutaneous melanoma is a tumor with rising incidence and a very poor prognosis at the disseminated stage. Melanomas are characterized by frequent mutations in BRAF and also by overexpression of fibroblast growth factor 2 (FGF2), offering opportunities for therapeutic intervention. We investigated inh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Metzner, Thomas, Bedeir, Alexandra, Held, Gerlinde, Peter-Vörösmarty, Barbara, Ghassemi, Sara, Heinzle, Christine, Spiegl-Kreinecker, Sabine, Marian, Brigitte, Holzmann, Klaus, Grasl-Kraupp, Bettina, Pirker, Christine, Micksche, Michael, Berger, Walter, Heffeter, Petra, Grusch, Michael
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3383623/
https://ncbi.nlm.nih.gov/pubmed/21753785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2011.177
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars